免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Caiman 5 Maryland

K号: K183180 · 2019-03-12

决定日期2019-03-12
产品代码GEI
咨询委员会SU 请注意,您提供的文本“SU”不足以进行翻译。请提供完整的描述性文本以便进行翻译。
决定实质等同

器械摘要

Caiman 5 Maryland is the device name listed in this FDA 510(k) record. The listed applicant is Aesculap, Inc.. It received FDA 510(k) clearance on 2019-03-12 under 510(k) number K183180. The device is classified under product code GEI. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Caiman 5 Maryland?

Caiman 5 Maryland is a medical device that received FDA 510(k) clearance on 2019-03-12. The listed applicant is Aesculap, Inc.. The 510(k) number is K183180.

When did Caiman 5 Maryland receive FDA 510(k) clearance?

Caiman 5 Maryland received FDA 510(k) clearance on 2019-03-12, under 510(k) number K183180.

Who is the listed applicant for Caiman 5 Maryland?

The FDA 510(k) record lists Aesculap, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Caiman 5 Maryland?

The FDA product code for Caiman 5 Maryland is GEI.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Aesculap, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

查看所有 34 个设备 →

相关器械(代码:GEI)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑